Participants 59 97 5
cetuximab-associated acnelike eruption
Participants 315 344 3
cetuximab-related facial rash
Participants 354 512 6
In all, 24 patients with metastatic colorectal cancer with cetuximab facial rash received twice daily pimecrolimus application for 5 weeks to half of the face
Participants 1211 1255 4
patients with cetuximab-related facial rash.
